PolyMedix Announces Positive Results From Phase 2 Clinical Trial With PMX-30063 First-in-Class Defensin-Mimetic Antibiotic – msnbc.com

Study in patients with Acute Bacterial Skin and Skin Structure Infections showed all three doses to have high clinical response rates and to be safe Conference Call Today at 9:00 a.m. ET RADNOR, Pa., April 23, 2012 (GLOBE NEWSWIRE) — PolyMedix …